Regulation of T-cell responses by PTEN

被引:59
作者
Buckler, Jodi L. [1 ]
Liu, Xiaohe [1 ]
Turka, Laurence A. [1 ]
机构
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
关键词
Tcells; cell activation; costimulation;
D O I
10.1111/j.1600-065X.2008.00650.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The phosphoinositide 3-kinase (PI3K) signaling pathway plays a critical role in the development, activation, and homeostasis of T cells by modulating the expression of survival and mitogenic factors in response to a variety of stimuli. Ligation of the antigen receptor, costimulatory molecules, and cytokine receptors activate PI3K, resulting in the production of the lipid second messenger phosphatidylinositol-3,4,5-triphosphate (PIP(3)). A number of molecules help to regulate the activity of this pathway, including the lipid phosphatase PTEN (phosphatase and tensin homolog deleted on chromosome 10). By limiting the amount of PIP(3) available within the cell, PTEN directly opposes PI3K activity and influences the selection of developing thymocytes as well as the activation requirements of mature T cells. T cells with unchecked PI3K activity, as a result of PTEN deficiency, contribute to the development of both autoimmune disease and lymphoma. This review dissects our current understanding of PI3K and PTEN and discusses why appropriate balance of these molecules is necessary to maintain normal T-cell responses.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 89 条
[21]   Bim is a suppressor of Myc-induced mouse B cell leukemia [J].
Egle, A ;
Harris, AW ;
Bouillet, P ;
Cory, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) :6164-6169
[22]   Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells [J].
Fang, D ;
Wang, HY ;
Fang, N ;
Altman, Y ;
Elly, C ;
Liu, YC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :4872-4878
[23]   Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells [J].
Fang, DY ;
Liu, YC .
NATURE IMMUNOLOGY, 2001, 2 (09) :870-875
[24]   Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling [J].
Fruman, DA .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (03) :314-320
[25]   Phosphoinositide binding domains: Embracing 3-phosphate [J].
Fruman, DA ;
Rameh, LE ;
Cantley, LC .
CELL, 1999, 97 (07) :817-820
[26]   Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α [J].
Fruman, DA ;
Snapper, SB ;
Yballe, CM ;
Davidson, L ;
Yu, JY ;
Alt, FW ;
Cantley, LC .
SCIENCE, 1999, 283 (5400) :393-397
[27]  
GonzalezGarcia A, 1997, J BIOL CHEM, V272, P10220
[28]   Multistep pathogenesis of autoimmune disease [J].
Goodnow, Christopher C. .
CELL, 2007, 130 (01) :25-35
[29]   The B7 family revisited [J].
Greenwald, RJ ;
Freeman, GJ ;
Sharpe, AH .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :515-548
[30]   New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway [J].
Gu, HH ;
Maeda, H ;
Moon, JJ ;
Lord, JD ;
Yoakim, M ;
Nelson, BH ;
Neel, BG .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (19) :7109-7120